Actinium Pharmaceuticals, Inc. (ATNM.OB) Set To Join Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes
6/17/2014 12:52:47 PM
NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, is set to join the broad-market Russell 3000® Index as well as the Russell 2000® , Russell Global and Russell Microcap® indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes.
Help employers find you! Check out all the jobs and post your resume.
comments powered by